Sunday, July 21, 2024
Home SCIENCE & RESEARCH

SCIENCE & RESEARCH

The OnLook news magazine widely covers the out comes of scientific research in the sectors like health, food and beauty and also regularly publishes research papers from top universities across the world.

Surprising

Surprising lack of association between stress and migraine revealed

Surprising it might sound, but a new study has found lack of association between stress and migraine. The research by the University of Calgary and...
Oramed

Oramed provides doses to patients across multiple sites

Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
Grifols

Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment

Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
Soterix

Soterix announces expanded clinical trials for Alzheimer’s disease

Soterix Medical Inc has announced expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer's disease and Mild Cognitive Impairment. The company is a leaing...
Covid-19

Covid-19 investigational therapeutics to be analysed in big clinical trials

Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
NIH

NIH starts study of Covid infection and multisystem inflammatory syndrome

NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children This includes multisystem inflammatory...
Covid-19 vaccine

Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine

Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
Lilly's

Lilly’s tirzepatide brings down body weight in people with type 2 diabetes

Lilly's Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes. This was achieved after 40 weeks of...
Covid-19 Doctor

Covid immunity lasts for many months, says study of healthcare workers

In a relief to healthcare workers who put their lives under risk while treating those with Covid-19, new findings from a study of thousands...
FDA

FDA gives nod to Saxenda for adoloscents’ obesity treatment

Novo Nordisk has said that the United States Food and Drug Administration (FDA) approved an updated label for Saxenda (liraglutide) injection 3 mg for...